The COURAGE trial addresses a persistent issue with GLP-1 therapies: unintended muscle loss
The protective effect appears strongest in patients who achieve 10% or greater body weight reduction, though benefits emerge at lower weight-loss thresholds too
OVERVIEW GHK-Cu, a copper peptide found abundantly in the human body, which re energizes skin cells and creates an optimal environment for skin-cell healthspan
Most frequently described adverse effects were constipation (19, 46.3%), nausea (15, 36.6%), asthenia (11, 26.8%), hyporexia (9, 22%), weight loss (4, 9.8%), sleep disturbance (4, 9.8%), dizziness (3, 7.3%), cognitive complaints (3, 7.3%), and pruritus (2, 4.8%)
Simulated descent v dexamethasone in treatment of acute mountain sickness: a randomised trial